Cytokinetics Inc (CYTK) — Capital Reinvestment Ratio
Cytokinetics Inc (CYTK) has a Capital Reinvestment Ratio of 0.13x as of December 2020, meaning it reinvests 0% of its operating cash flow ($52.15 Million) in capital expenditures ($6.55 Million). Check how tangible is Cytokinetics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cytokinetics Inc Capital Reinvestment Ratio (2009–2020)
This chart tracks Cytokinetics Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see CYTK operating cash flow.
Annual Capital Reinvestment Ratio for Cytokinetics Inc (2009–2020)
Year-by-year Capital Reinvestment Ratio for Cytokinetics Inc from 2009 to 2020. See CYTK free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.24x | $8.94 Million | $11.05 Million | ▲ +2763.6% |
| 2016 | 0.04x | $36.98 Million | $1.60 Million | ▼ -62.5% |
| 2015 | 0.12x | $4.88 Million | $562.00K | ▲ +76.1% |
| 2009 | 0.07x | $8.42 Million | $550.00K | — |